Article
07 May 2026
FinCEN Raises Alarm On Healthcare Fraud
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
04 May 2026
DOJ’s FCA Enforcement Priorities — Insights From The Deputy Assistant Attorney General
Article
08 Apr 2026
From Compliance Department To Counterintelligence Function
Article
07 Apr 2026
A New Era For Fraud Prosecutions At DOJ
Article
02 Apr 2026
Spring Cleaning: The Trump Administration Continues Push To Root Out Federal Program Fraud
Article
30 Mar 2026
FinCEN Raises Alarm On Healthcare Fraud
Article
27 Mar 2026
Aetna Pays $117.7 Million As Government Intensifies Medicare Advantage Scrutiny
Article
25 Mar 2026
Villarreal v. Texas: SCOTUS Upholds Qualified Orders Prohibiting Defense Counsel From Managing Their Client’s Ongoing Testimony During Overnight Recesses
Article
19 Mar 2026
Oh, The Places The False Claims Act Will Go (Even To San Diego)
Article
18 Mar 2026
Skipping The Conference But Heard Loud And Clear: DOJ's "Department-Wide" Message To The White Collar Bar
Article
17 Mar 2026
OIG's Managed Care Compliance Roadmap: Key Risk Areas For Medicare Advantage
Article
16 Mar 2026
Genetic Testing Under The Microscope: OIG Reports Surge In Medicare Lab Spending
Article
12 Mar 2026
What You Need To Know About The SEC's Enforcement Manual Update
Article
09 Mar 2026
A Clearer Path Forward? SDNY's New Corporate Disclosure Framework
Article
25 Feb 2026
Follow The Money: DOJ Secures First Conviction Of A Banker For Laundering Healthcare Fraud Proceeds
Article
20 Feb 2026
Stepping Up To The Mic: SEC Enforcement Director Speaks On Priorities And Policies
Article
11 Feb 2026
DOJ And HHS-OIG Report A Record Year Of Enforcement, With Healthcare Fraud At The Center
Article
27 Jan 2026
DOJ's FY 2025 FCA Numbers Send A Clear Message: Enforcement Risk Is Rising
Article
23 Jan 2026
Seeing Double: Trump Administration To Create New DOJ Fraud Enforcement Division
Article
21 Jan 2026
SEC And DOJ Flex On Life Sciences Insider Trading